UNDERWRITING AGREEMENT between RUTHIGEN, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters RUTHIGEN, INC.Underwriting Agreement • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • New York
The undersigned, Ruthigen, Inc. a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
Form of Representative’s Warrant AgreementRuthigen, Inc. • October 16th, 2013 • Pharmaceutical preparations • New York
THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
Indemnification AgreementIndemnification Agreement • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is made and entered into as of __________________, 20___, by and between Ruthigen, Inc., a Delaware corporation (the “Company”), and _______________ (“Indemnitee”).
License and Supply AgreementLicense and Supply Agreement • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • California
THIS LICENSE AND SUPPLY AGREEMENT (the “Agreement”) is executed as of the 23 day of May, 2013, shall become effective upon the closing of an IPO (as hereinafter defined) (the “Effective Date”), and is entered into by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”) and Oculus Innovative Sciences, Inc., a Delaware corporation (hereinafter referred to as “Oculus”). Oculus and Ruthigen are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
THIRD AMENDMENT TO LEASELease • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE (this “Amendment”) dated as of Oct 3, 2013 ls entered into between SR OFFICE PROPERTIES LLC, a California limited liability company (“Landlord”) and RUTHIGEN, INC., a Nevada corporation (“Tenant”).
AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 16th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • California
This AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is made and entered into as of October 9, 2013 and shall become effective upon the closing of an IPO (as defined in the License Agreement). This Amendment amends that certain License and Supply Agreement dated as of May 23, 2013 (the “License Agreement”), by and between Ruthigen, Inc., a Delaware corporation (“Ruthigen”) and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus”). Capitalized terms used and not defined herein shall have the meanings given to them in the License Agreement.
